↓ Skip to main content

Cochrane Database of Systematic Reviews

Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease

Overview of attention for article published in Cochrane database of systematic reviews, October 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

blogs
1 blog
twitter
5 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
189 Dimensions

Readers on

mendeley
169 Mendeley
citeulike
1 CiteULike
Title
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease
Published in
Cochrane database of systematic reviews, October 2006
DOI 10.1002/14651858.cd006257
Pubmed ID
Authors

Giovanni FM Strippoli, Carmen Bonifati, Maria E Craig, Sankar D Navaneethan, Jonathan C Craig

Abstract

Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor antagonists (AIIRA) are considered to be equally effective for patients with diabetic kidney disease (DKD), but renal and not mortality outcomes have usually been considered.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 169 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 166 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 35 21%
Researcher 21 12%
Student > Bachelor 16 9%
Other 14 8%
Student > Postgraduate 14 8%
Other 32 19%
Unknown 37 22%
Readers by discipline Count As %
Medicine and Dentistry 89 53%
Agricultural and Biological Sciences 8 5%
Nursing and Health Professions 8 5%
Pharmacology, Toxicology and Pharmaceutical Science 7 4%
Neuroscience 3 2%
Other 16 9%
Unknown 38 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2022.
All research outputs
#2,149,708
of 20,754,071 outputs
Outputs from Cochrane database of systematic reviews
#4,755
of 12,108 outputs
Outputs of similar age
#20,677
of 248,563 outputs
Outputs of similar age from Cochrane database of systematic reviews
#187
of 485 outputs
Altmetric has tracked 20,754,071 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,108 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.3. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 248,563 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 485 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.